indapamide has been researched along with Metabolic Diseases in 3 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "to assess the potential of fixed perindopril/indapamide combination (FPIC) to improve angioprotection in patients with arterial hypertension (AP) with various efficacy of preceding therapy with combination of losartan and hydrochlorothiazide (HCTZ)." | 7.85 | [Optimization of Control of Blood Pressure, Metabolic Disorders and Target Organs Protection With Fixed Perindopril and Indapamide Combination in Treated Patients With Arterial Hypertension]. ( Chumachek, EV; Hripaeva, VJ; Ledyaeva, AA; Nedogoda, SV; Palashkin, RV; Salasyuk, AS; Smirnova, VO; Tsoma, VV, 2017) |
| "to assess the potential of fixed perindopril/indapamide combination (FPIC) to improve angioprotection in patients with arterial hypertension (AP) with various efficacy of preceding therapy with combination of losartan and hydrochlorothiazide (HCTZ)." | 3.85 | [Optimization of Control of Blood Pressure, Metabolic Disorders and Target Organs Protection With Fixed Perindopril and Indapamide Combination in Treated Patients With Arterial Hypertension]. ( Chumachek, EV; Hripaeva, VJ; Ledyaeva, AA; Nedogoda, SV; Palashkin, RV; Salasyuk, AS; Smirnova, VO; Tsoma, VV, 2017) |
| "Telmisartan was more effective, whereas indapamide had better pharmacoeconomic benefits." | 2.80 | Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure. ( Liu, Z; Lu, F; Peng, J; Tang, M; Wang, Z; Zhang, H; Zhang, W; Zhao, Y; Zhong, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, J | 1 |
| Zhao, Y | 1 |
| Zhang, H | 1 |
| Liu, Z | 1 |
| Wang, Z | 1 |
| Tang, M | 1 |
| Zhong, M | 1 |
| Lu, F | 1 |
| Zhang, W | 1 |
| Nedogoda, SV | 1 |
| Chumachek, EV | 1 |
| Ledyaeva, AA | 1 |
| Tsoma, VV | 1 |
| Salasyuk, AS | 1 |
| Smirnova, VO | 1 |
| Hripaeva, VJ | 1 |
| Palashkin, RV | 1 |
| Passa, P | 1 |
2 trials available for indapamide and Metabolic Diseases
| Article | Year |
|---|---|
Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; China; Double-Blind Method | 2015 |
[Cicletanine tolerance in hypertensive patients with metabolic disorders].
Topics: Antihypertensive Agents; Diuretics; Double-Blind Method; Drug Evaluation; Female; Humans; Hypertensi | 1989 |
1 other study available for indapamide and Metabolic Diseases
| Article | Year |
|---|---|
[Optimization of Control of Blood Pressure, Metabolic Disorders and Target Organs Protection With Fixed Perindopril and Indapamide Combination in Treated Patients With Arterial Hypertension].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; H | 2017 |